Identification | More | [Name]
Cyclobutyl bromide | [CAS]
4399-47-7 | [Synonyms]
BROMOCYCLOBUTANE CYCLOBUTYL BROMIDE Cyclobutane, bromo- Cyclobutane,bromo- Cyclobutylbromide,96% Bromocyclobutane,95% Cyclobutyl bromide, pure, 97% Cyclobutyl halide Cyclobutyl bromide, 97%, pure | [EINECS(EC#)]
224-530-9 | [Molecular Formula]
C4H7Br | [MDL Number]
MFCD00001317 | [Molecular Weight]
135 | [MOL File]
4399-47-7.mol |
Chemical Properties | Back Directory | [Appearance]
CLEAR COLOURLESS LIQUID | [Boiling point ]
108 °C(lit.)
| [density ]
1.434 g/mL at 25 °C(lit.)
| [refractive index ]
n20/D 1.479(lit.)
| [Fp ]
72 °F
| [storage temp. ]
0-6°C | [solubility ]
Chloroform (Slightly), Methanol (Slightly) | [form ]
Liquid | [color ]
Clear colorless | [Water Solubility ]
Insoluble | [Sensitive ]
Light Sensitive | [BRN ]
1900415 | [InChIKey]
KXVUSQIDCZRUKF-UHFFFAOYSA-N | [CAS DataBase Reference]
4399-47-7(CAS DataBase Reference) | [NIST Chemistry Reference]
Cyclobutyl bromide(4399-47-7) |
Safety Data | Back Directory | [Hazard Codes ]
Xi | [Risk Statements ]
R10:Flammable. R36/37/38:Irritating to eyes, respiratory system and skin . R20/21/22:Harmful by inhalation, in contact with skin and if swallowed . | [Safety Statements ]
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice . S36:Wear suitable protective clothing . S36/37/39:Wear suitable protective clothing, gloves and eye/face protection . S16:Keep away from sources of ignition-No smoking . | [RIDADR ]
UN 1993 3/PG 2
| [WGK Germany ]
3
| [F ]
8 | [HazardClass ]
3 | [PackingGroup ]
II | [HS Code ]
29038900 |
Hazard Information | Back Directory | [Chemical Properties]
CLEAR COLOURLESS LIQUID | [Uses]
Cyclobutyl bromide is a cyclopentyl compound that has an hydroxyl group.
It is a potent inhibitor of the CB2 receptor, which is primarily
expressed on cells of the immune system. Cyclobutyl bromide has been
shown to inhibit the uptake of uv light and also has anti-inflammatory
properties. Studies have confirmed that this drug inhibits the
production of cytokines and chemokines in chronic bronchitis patients,
as well as other inflammatory diseases such as rheumatoid arthritis. |
|
|